Literature DB >> 15988322

15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock.

Jennifer M Kaplan1, James A Cook, Paul W Hake, Michael O'Connor, Timothy J Burroughs, Basilia Zingarelli.   

Abstract

Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a nuclear receptor that requires ligand activation for transcription. Experimental studies have shown that 15-deoxy-Delta-PGJ2 (15d-PGJ2) is a natural PPARgamma ligand which has potent anti-inflammatory properties. This study was designed to examine the effect and the molecular mechanisms of 15d-PGJ2 on tissue neutrophil infiltration and survival in endotoxic shock. Male Swiss albino mice were subjected to intraperitoneal injection of Escherichia coli lipopolysaccharide (LPS, 25 mg/kg). Three hours after LPS mice received vehicle or 15d-PGJ2 (1 mg/kg) and continued treatment every 12 hours. Survival was monitored for 72 hours. In a separate experiment, mice were sacrificed 6 hours after LPS and tissue examined. In vehicle-treated mice, LPS injection resulted in a survival rate of 9%. Marked lung injury was characterized by hemorrhage, infiltration of inflammatory cells and reduction of alveolar space. Elevated levels of myeloperoxidase activity in lung and small intestine were indicative of infiltration of neutrophils. Increased expression of intercellular adhesion molecule-1, vascular cellular adhesion molecule-1 and E-selectin were observed in the lung and small intestine. These inflammatory events were associated with reduced expression of PPARgamma and with activation of nuclear factor-kappaB (NF-kappaB) in the lung. Treatment with 15d-PGJ2 improved survival rate to 55%, downregulated expression of adhesion molecules and reduced neutrophil infiltration in tissues. These beneficial effects were associated with reduced activation of NF-kappaB DNA binding, whereas expression and DNA binding of PPARgamma and expression of the cytoprotective heat shock protein (HSP) 70 were increased in the lung. Our data demonstrate that 15d-PGJ2 ameliorates endotoxic shock most likely through repressing the proinflammatory pathway of NF-kappaB and enhancement of the cytoprotective heat shock response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15988322     DOI: 10.1097/01.shk.0000167108.88376.f2

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  43 in total

1.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

2.  Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis.

Authors:  Jennifer Kaplan; Marchele Nowell; Ranjit Chima; Basilia Zingarelli
Journal:  Innate Immun       Date:  2013-09-12       Impact factor: 2.680

Review 3.  Involvement of PPAR nuclear receptors in tissue injury and wound repair.

Authors:  Liliane Michalik; Walter Wahli
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

4.  Thy-1 signals through PPARγ to promote lipofibroblast differentiation in the developing lung.

Authors:  Brian M Varisco; Namasivayam Ambalavanan; Jeffrey A Whitsett; James S Hagood
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-20       Impact factor: 6.914

5.  Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice.

Authors:  Xin Lv; Jian-Gang Song; Hong-Hai Li; Jun-Ping Ao; Ping Zhang; Ye-Sheng Li; Shao-Li Song; Xiang-Rui Wang
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

6.  Combined zinc supplementation with proinsulin C-peptide treatment decreases the inflammatory response and mortality in murine polymicrobial sepsis.

Authors:  Siarhei Slinko; Giovanna Piraino; Paul W Hake; John R Ledford; Michael O'Connor; Patrick Lahni; Patrick D Solan; Hector R Wong; Basilia Zingarelli
Journal:  Shock       Date:  2014-04       Impact factor: 3.454

Review 7.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  A PPARγ AGONIST ENHANCES BACTERIAL CLEARANCE THROUGH NEUTROPHIL EXTRACELLULAR TRAP FORMATION AND IMPROVES SURVIVAL IN SEPSIS.

Authors:  Cláudia V Araújo; Clarissa Campbell; Cassiano F Gonçalves-de-Albuquerque; Raphael Molinaro; Mark J Cody; Christian C Yost; Patricia T Bozza; Guy A Zimmerman; Andrew S Weyrich; Hugo C Castro-Faria-Neto; Adriana R Silva
Journal:  Shock       Date:  2016-04       Impact factor: 3.454

9.  Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock.

Authors:  Ranjit S Chima; Paul W Hake; Giovanna Piraino; Prajakta Mangeshkar; Alvin Denenberg; Basilia Zingarelli
Journal:  Crit Care Med       Date:  2008-10       Impact factor: 7.598

10.  Changes in peroxisome proliferator-activated receptor-gamma activity in children with septic shock.

Authors:  Jennifer M Kaplan; Alvin Denenberg; Marie Monaco; Marchele Nowell; Hector Wong; Basilia Zingarelli
Journal:  Intensive Care Med       Date:  2009-09-17       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.